India Coffee House Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : India Coffee House

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mohan Marette who wrote (8855)	10/23/1999 7:47:00 PM
From: Mohan Marette	Read Replies (1) of 12475

Neuland Labs rights at 1:2 neulandindia.com HYDERABAD: Neuland Laboratories Ltd has decided to go in for a rights issue in the ratio of one rights share of Rs. 10 each at a premium of Rs. 50 for every two equity shares held. The board, which met here on Saturday, has approved the proposal. It has taken on record the unaudited financial results for the second quarter of the current fiscal ended September 30 and recommended a dividend of 12 per cent for the year 1998-99, according to the Managing Director, Dr. D.R. Rao. The company has also received US-FDA approval for Ranitidine form-I for its unit at Pashamylaram near here.....(BL 10/23/99)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next